Company* (Country; Symbol) Company* (Country; Symbol) Type/Product Area Terms/Details (Date)
ABR-Affinity BioReagents* Genesis Biotech Inc.* and Good Biotech Corp.* Distribution agreements on research antibodies Genesis Biotech manufactures antibodies focusing on gene function and discovery, while Good Biotech is focused on disease research; ABR-Affinity will distribute the products in the U.S. (9/13)
Affymetrix Inc. (AFFX) Empire Genomics LLC* Nonexclusive, worldwide license agreement to a number of Affymetrix patents The patents cover the manufacturing, use and sales of nucleic acid microarrays and related products and services for comparative genomic hybridization (9/7)
Apollo Life Sciences (Australia; BE:A3L) Millipore Corp. (NYSE:MIL) Agreement to produce human leukaemia inhibitor factor for Millipore Apollo will use its human cell-expressed protein technology to make the hLIF, which Millipore will sell worldwide to researchers for use in preventing stem cells from differentiating (8/21)
Avecia Biologics Ltd.* (UK) Renovo Group plc (UK; LSE:RNVO) Agreement for process development and manufacture of Renovo's developmental product, Prevascar, a therapeutic formulation of human recombinant interleukin-10 Avecia will carry out development work to optimize the drug manufacturing process and scale-up; it also will conduct further cGMP manufacture of IL-10 in Avecia's biologics facilities (10/1)
Columbia Laboratories Inc. (CBRX) Ascend Therapeutics Inc.* Exclusive, five-year license and supply agreement for the sales and marketing of Columbia's Prochieve 4% progesterone gel, which is approved for treating secondary amenorrhea Ascend will purchase product from Columbia at a transfer price equal to 35% of its net selling price in a deal that includes increasing minimum annual purchase obligations (9/27)
GammaCan International Inc. (Israel; OTC BB: GCAN) DCI Biologicals Inc.* Plasma supply agreement DCI Biologicals will collect plasma from vitiglo donors for the manufacture of VitiGam for melanoma; GammaCan made its exclusive supply agreement with Life Therapeutics Inc. to nonexclusive (10/1)
MicroIslet Inc. (OTC BB:MIIS) Progenitor Cell Therapy LLC* Manufacturing agreement for MicroIslet-P, a product consisting of microencapsulated islets for implantation into the abdominal cavity that is designed to provide self-regulating blood glucose control MicroIslet-P will be manufactured at PCT's California facility under the cGMP for use in MicroIslet's ongoing preclinical studies and planned clinical programs (9/17)
Molecular Insight Pharmaceuticals Inc. (MIPI) Poniard Pharmaceuticals Inc. (PARD) Agreement under which Molecular Insight purchased a commercial-scale radio-pharmaceutical manufacturing facility in Denton, Texas, from NeoRx Manufacturing Group Inc., a subsidiary of Poniard The $3M transaction allows Molecular Insight to expand its manufacturing capabilities (10/3)
Sirtex Medical Ltd. (Australia; ASX:SRX) Synmosa Biopharma Corp.* (Taiwan) Licensing agreement that covers the marketing in Taiwan of Sirtex's SIR-Spheres microspheres for treating advanced liver cancer Sirtex estimated it would take one or two years to gain approval in Taiwan (8/17)
Valeant Pharmaceuticals International (NYSE:VRX) Ascend Therapeutics* Exclusive rights agreement to promote its migraine nasal spray Migranal to more than 5,500 OB/GYNs in the U.S. Valeant will continue to market Migranal to physicians outside the OB/BYN specialty area and retain all other responsibilities for the product (10/2)
ValiRx plc (UK: LSE:VAL) Chroma Therapeutics* (UK) Full license agreement to commercialize a non-invasive diagnostic technology patent developed by Chroma that identifies epigenetic signal changes that occur in cancer-related illnesses ValiRx will pay Chroma royalties on any future sales resulting from commercialization of the Nucleosomics technology (10/15)
Notes:

* Private companies are indicated with an asterisk.

Unless otherwise noted, stock symbols listed are on the Nasdaq market.

ASX = Australian Stock Exchange; BE = Berlin Stock Exchange; LSE = London Stock Exchange; NYSE = New York Stock Exchange; OTC BB = Over-the-Counter Bulletin Board.